Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: in vitro quantitation of effector cell populations with p17 and p24 specificities - PubMed (original) (raw)

Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: in vitro quantitation of effector cell populations with p17 and p24 specificities

R A Koup et al. J Exp Med. 1991.

Abstract

The presence of cytotoxic T lymphocytes (CTL) to the gag antigens of human immunodeficiency virus (HIV) has been described in infected populations. We found that the majority of this immune response as measured in bulk CTL assays of unstimulated peripheral blood mononuclear cells (PBMC) is directed against the p24 component of the p55 gag precursor protein. Using limiting dilution analysis of this effector cell population we confirm that the majority of activated gag-specific CTL circulating in the PBMC of infected hemophilic patients are directed at p24 determinants and are present at frequencies of 1/36,000 to 1/86,000 lymphocytes. By performing in vitro stimulation after limiting dilution, the precursor population of gag-specific CTL are characterized and quantitated. HIV gag-specific CTL precursors are identified at frequencies of 1/1700 to 1/17,000 lymphocytes and are made up of cells with both p17 and p24 specificities. No HIV gag-specific CTL precursor cells are identified in the PBMC of HIV-uninfected individuals. These studies demonstrate that CTL directed at both p17 and p24 determinants make up the cellular immune repertoire in HIV-infected individuals but that only the p24-specific CTL are routinely found in an activated state in the circulation.

PubMed Disclaimer

Cited by

Persistent high frequency of human immunodeficiency virus-specific cytotoxic T cells in peripheral blood of infected donors.
Moss PA, Rowland-Jones SL, Frodsham PM, McAdam S, Giangrande P, McMichael AJ, Bell JI. Moss PA, et al. Proc Natl Acad Sci U S A. 1995 Jun 20;92(13):5773-7. doi: 10.1073/pnas.92.13.5773. Proc Natl Acad Sci U S A. 1995. PMID: 7597028 Free PMC article.
Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells.
Bhardwaj N, Bender A, Gonzalez N, Bui LK, Garrett MC, Steinman RM. Bhardwaj N, et al. J Clin Invest. 1994 Aug;94(2):797-807. doi: 10.1172/JCI117399. J Clin Invest. 1994. PMID: 8040335 Free PMC article.
Characteristics of the intrahepatic cytotoxic T lymphocyte response in chronic hepatitis C virus infection.
Koziel MJ, Walker BD. Koziel MJ, et al. Springer Semin Immunopathol. 1997;19(1):69-83. doi: 10.1007/BF00945026. Springer Semin Immunopathol. 1997. PMID: 9266632 Review.
Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.
Koup RA, Safrit JT, Cao Y, Andrews CA, McLeod G, Borkowsky W, Farthing C, Ho DD. Koup RA, et al. J Virol. 1994 Jul;68(7):4650-5. doi: 10.1128/JVI.68.7.4650-4655.1994. J Virol. 1994. PMID: 8207839 Free PMC article.
High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease.
Elovaara I, Koenig S, Brewah AY, Woods RM, Lehky T, Jacobson S. Elovaara I, et al. J Exp Med. 1993 Jun 1;177(6):1567-73. doi: 10.1084/jem.177.6.1567. J Exp Med. 1993. PMID: 8496677 Free PMC article.

References

1. Int Immunol. 1990;2(8):707-12 - PubMed
1. J Immunol. 1981 Aug;127(2):487-91 - PubMed
1. J Virol. 1989 Feb;63(2):584-90 - PubMed
1. J Pediatr. 1986 Apr;108(4):504-10 - PubMed
1. J Clin Invest. 1985 Oct;76(4):1699-704 - PubMed

Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: in vitro quantitation of effector cell populations with p17 and p24 specificities - PubMed (original) (raw)